Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Laurence Smolley, MD, is Chairman of the Department of Pulmonary Medicine and Medical Director of the Sleep Disorders Center at Cleveland Clinic Florida, Weston. He also serves as Staff in the Department of Pulmonary Medicine. His specialty interests include lung cancers, asthma, breathlessness and sleep disorders such as snoring, excessive daytime sleepiness, obstructive sleep apnea and narcolepsy. Dr. Smolley is certified by the American Board of Internal Medicine, with subspecialty certification in pulmonary diseases and critical care medicine. He is also certified by the American Board of Sleep Medicine.
After completing his Bachelor's of Science degree in chemistry at Yale University in 1972, Dr. Smolley received his medical degree from the New York University School of Medicine in New York City in 1976. He completed advanced training with an internal medicine residency at Downstate-Kings County Medical Center, Brooklyn, N.Y., followed by a pulmonary fellowship at Jackson Memorial Hospital/University of Miami, Fla.
Prior to his appointment to Cleveland Clinic in 1995, Dr. Smolley was Director of Pulmonary Rehabilitation and of the Sleep Disorders Center of the Baptist Medical Center in Jacksonville, Fla. (1986-1994). He also had been Acting Chief, then Chief of the Pulmonary Section at Miami Veterans Administration Hospital (1983-1986), and Assistant Professor of Medicine at the University of Miami School of Medicine, Fla.(1981-1986).
Dr. Smolley is involved in a number of professional societies. He is a Fellow of the American Academy of Sleep Medicine and of the American College of Chest Physicians. He is a member of the American Thoracic Society, the Florida Sleep Medicine Society and the Society of Critical Care Medicine. Dr. Smolley has published books, book chapters, articles and abstracts related to his specialty interests.
Critical care medicine, granulomatous lung diseases, sleep disorders
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/3/2012, Dr. Smolley has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.